acids (Tyraa and Gluas), is unique to PCBMP. It is of further interest that the corresponding tetrapeptide from the Ha of a human IgM PCBMP, Fr, is Phe-TyrMet-Asp (15) .
In contrast to PCBMP, the structure of the phosphocholine-binding site of CRP has not been determined, even though the primary structure has been elucidated (16) . Weak homologies between the NHz-terminal amino acid sequence of CRP and the CHa domain of IgG were noted (17) but their significance was disputed when the complete amino acid sequence of CRP was used for the comparison (16) . However, recently Young and Williams (18) pointed out that despite the lack of strong overall sequence homologies between IgG and CRP, there are regions in the primary sequence of CRP that resemble the Hx and H2 regions of murine PCBMP and that the main contacting amino acids of the PCBMP hapten-binding site appear to be present in CRP. These authors suggested that the phosphocholine-binding sites of CRP and PCBMP may have common structural elements. In this study, such common structural elements were sought by using monoclonal antibodies with specificity for idiotypic determinants on the PCBMP 7N-hexyloctadecane plasma cell (HOPC) HOPC 8.
Materials and Methods
Reagents and Chromatographic Media. Sephadex G-25 and Sepharose 4B were obtained from Pharmacia Fine Chemicals, Piscataway, N. J.; microgranular DEAE-cellulose (Whatman DE-52) from H. Reeve Angel, Clifton, N. J.; electrophoresis grade acrylamide, N,N'-methylene-bisacrylamide, sodium dodecyl sulfate (SDS), and ammonium persulfate from Bio-Rad Labora-
• .
• 125 tories, Richmond, Cahf., career-free Na[ I] from Amersham Corp., Arlington Heights, Ill.; lactoperoxidase from Worthington, Biochemical Corp., Freehold, N. J.; phosphocholine chloride, calcium salt, and bovine serum albumin (BSA) from Sigma Chemical Co., St. Louis, Mo.; dinonylphthalate from ICN K & K Laboratories, Inc., Plainview, N. Y.; and dibutylphthalate from Fisher Scientific Co., Pittsburgh, Pa.
Phosphocholine was coupled to Sepharose as described by Chesebro and Metzger (19) . Paradiazonium phosphocholine, a gift from Dr. D. Ewert, University of Alabama in Birmingham, Birmingham, Ala., was used to couple phosphocholine to keyhole limpet hemocyanin (KLH) (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.).
Purification and Radioiodination of CRP and HOPC 8. Human CRP was purified from ascitic fluid by a previously described method (20) , based on the Ca++-dependent affinity of CRP for phosphocholine. The protein was judged pure by eleetrophoresis on 5-20% polyacrylamide gradient slab gels (21) containing 0.1% SDS. Purified CRP was labeled with a25I by the lactoperoxidase method of Marchalonis (22) . The radioiodination mixture was then applied on a 3-ml phosphocholine-Sepharose 4B column and equilibrated in 0.1 M borate-buffered saline, pH 8.5, containing 2 mM CaCI2. The column was washed with the same buffer until the radioactivity of the effluent was negligible. Bound 125I-CRP was then eluted with the same buffer, containing 2 mM EDTA instead of CaCI2. The specific radioactivity of x2SI-CRP varied between 0.6 and 0.9 ttCi/~g. More than 98% of the radioactivity was protein bound, as determined by trichloroacetic acid (TCA~ precipitation.
The mouse PCBMP HOPC 8 (a,~¢) (23) was purified from ascites fluid of mice bearing the myeloma HOPC 8 by methods described by Chesebro and Metzger (19) . HOPC 8 was radioiodinated with ~2sI by the lactoperoxidase method (22) in the presence of a 20-fold molar excess of phosphocholine to protect the binding site. 12SI-HOPC 8 was separated from free 125I and phosphocholine by gel filtration on a 0.5-× 50-cm Sephadex G-25 column, followed by extensive dialysis against 0.01 M Tris-HCl, 0.15 M NaCI, pH 7.2. The specific radioactivity of 12SI-HOPC 8 varied between 1 and 3 ttCi/~g. More than 97% of the radioactivity was TCAprecipitable.
Monoclonal Anti-ldiotypic Antibodies (MAB). Monoclonal antibodies reactive with idiotypic determinants expressed by HOPC-8 were prepared by immunizing A/J mice with purified HOPC-8 myeloma protein and then fusing lymph node cells from these mice with the myeloma P3-NS1/1-Ag4-1 (24) . The details of preparation, purification, specificity analysis, and biological activities of these MAB have been described (25, 26) . Briefly, the MAB AB 1-2 and GB4-10 were of 71,r class, and reacted with HOPC 8 and TEPC 15 but no other murine PCBMP, and both reacted with an idiotope that was dependent on light and heavy chain association for expression. Although these antibodies are very similar, detailed analysis has revealed that they differ slightly in their fine specifieities. 2 MAB, EB3-7 (Tx,K) which reacted with an idiotypic determinant expressed by J558 (a,~,) an otl---~3 dextran-binding mouse myeloma protein was used in experiments as a control antibody.
PnC. PnC was isolated from rough Streptococcus pneumoniae, strain R36A (American Type Culture Collection, Rockville, Md.), as described by Liu and Gotschlich (27) , except that the final enzymatic digestion step was omitted.
Coupling of PnC to Sheep ETythrocytes. PnC was coupled to sheep erythrocytes (E) by the chromium chloride method of Cosenza et al. (28) : equal volumes of E (50% vol:vol), PnC (31-250/~g/ml), and chromium chloride (1 mg/ml) in 0.01 M Tris-HC1, 0.15 M NaCI, pH 7.2, were mixed and incubated at room temperature for 4 min. The sensitized erythrocytes (E-PnC) were washed three times with, and resuspended in the same buffer at a final concentration of 5 × 10 s cells/ml. Control E were prepared by omitting PnC from the chromium chloride reaction mixture.
Assays for Binding and Inhibition of Binding of teSI-CRP and I~I-HOPC 8 to E-PnC. Binding and
inhibition assays were performed in 0.01 M Tris-HC1, 0.15 M NaCI buffer, pH 7.2, containing either 2.5 mM Ca ++ or 1 mM EDTA, as indicated. In a typical binding experiment, E-PnC (5 × 10S/ml) sensitized with increasing amounts of PnC were mixed with 50/~1 of 125I-CRP (1.8 /zg/ml) or 125I-HOPC 8 (2.6 #g/ml). Controls consisted of mixtures of the radiolabeled proteins and nonsensitized, chromium chloride-treated E. The mixtures were incubated at room temperature for 30 min with occasional shaking. To separate free from cell-bound protein, the cells were centrifuged into an oil phase (29) . 30-p,1 aliquots from each reaction mixture were layered on top of 300 #1 of a mixture of dibutyl:dinonyl phthalate (2:1; vol:vol) in 400-~1 conical polypropylene tubes. Centrifugation was carried out for 90 s at 6,500 g in an Eppendorf microcentrifuge (Brinkmann Instruments, Inc., Westbury, N. Y.). The aqueous phase along with three-fourths of the oil mixture were removed, the tubes were cut just above the cell pellet, and the tips containing the cells were counted in a gamma counter to assess the amount of cellbound protein.
For inhibition experiments, E-PnC sensitized with 31/~g PnC/5 × l0 s E were utilized. The reaction mixtures consisted of 50/11 E-PnC (5 × 10S/ml), 25/tl 12SI-CRP (3.6/~g/ml) or 25/xl :2SI-HOPC 8 (5.3/xg/ml), and 25 #1 of inhibitor at various concentrations. After incubation at room temperature for 30 rain, the amount of cell-bound radiolabeled protein was determined as described above. Percent inhibition was calculated from a control mixture lacking the inhibitor.
Binding and Inhibition of Binding of tzSI-CRP and teSI-HOPC 8 to MAB.
Solid-phase assays were utilized for these studies. Polystyrene microwells (Removawell strips; Dynatech Laboratories, Inc., Dynatech Corp., Alexandria, Va.) were incubated with 300/tl of MAB solution (0.4-26 ~g/ml) in 0.01 M Tris-HCl~ 0.15 M NaCI buffer, pH 7.2, for 30 min at room temperature. The fluid was aspirated, the microwells washed with buffer, and incubated with 300/LI of a 10 mg/ ml solution of BSA in the same buffer to block remaining protein-binding sites. After a 30-min incubation at room temperature, the microwells were washed three times with buffer and used immediately. Control microwells were prepared by omitting the initial incubation step with MAB.
For binding studies, MAB-coated and BSA-coated mierowells (controls) were incubated overnight at 4°C with 300 ~1 of lzSI-CRP (0.36/~g/ml) or of x2SI-HOPC 8 (0.17 p.g/ml) in buffer containing either 2.5 mM Ca ++ or 1 mM EDTA. The fluid was aspirated, the microwells washed three times with the appropriate buffer, and counted in a gamma counter to assess the amount of bound, radiolabeled protein. Experimental values were corrected for the small amount of radioactivity bound to control BSA-coated tubes.
For inhibition experiments, microwells coated with an amount MAB calculated to result in -30% binding of the 125I-CRP or 12bI-HOPC 8 offered were used. Increasing concentrations of the inhibitor tested dissolved in 0.01 M Tris-HCl, 0.15 M NaCl, pH 7.2, containing 2.5 mM Ca ++ or 1 mM EDTA were added to the microwells, followed by 25/~l of 12SI-CRP (4.4 #g/ml) or 25 pl 12~I-HOPC 8 (2/xg/ml). After overnight incubation at 4°C, the fluid was aspirated, the microwells washed three times with buffer and the amount of bound radioactivity determined. Percent inhibition was calculated from a control lacking inhibitor after correcting all experimental values for the small amount of radioactivity bound nonspecifically to control, BSAcoated microwells.
Protein Determinations. Concentrations of purified proteins were determined spectrophoto-..... EI% metrically at 280 nm using an extmcuon coeffioent (lcm) of 19.5 CRP (30) and 15.0 for HOPC 8. For calculating molar concentrations, the molecular weight of the phosphocholinebinding subunit of each protein was utilized--21,000 for the noncovalent subunit of CRP (16) and 75,000 for the heavy-light chain monomer of HOPC 8 (31).
Results
As expected, both 125I-CRP and 125I-HOPC 8 bound equally well to E-PnC in buffer containing 2.5 mM Ca ++ (Fig. 1) . On a mole per mole basis, equimolar amounts of pentameric CRP and 7S monomer of HOPC 8 bound to the E-PnC throughout the linear portion of the dose-response curves. As shown, under the experimental conditions used, neither protein bound to control, chromium chloridetreated E. When this experiment was repeated using buffer containing 1 mM EDTA instead of Ca ++, the binding curve for 125I-HOPC 8 was identical to that shown in Fig. 1 , whereas the binding of 125I-CRP was completely abolished.
Binding of either radiolabeled protein to E-PnC could be inhibited by micromolar concentrations of phosphocholine (Fig. 2) . This is in agreement with previous data demonstrating that phosphocholine is a potent inhibitor of the precipitation reactions between either CRP (6) or HOPC 8 (10, 23) and PnC. Finally, the results of cross- The findings described above and the observation by Young and Williams (18) that certain regions of the CRP amino acid sequence are homologous to the first two hypervariable regions of the heavy chain of PCBMP, led us to examine the possible interaction between CRP and GB4-10, a monoclonal antibody with specificity for idiotypic determinants on HOPC 8. Initial experiments indicated that GB4-10 at micromolar concentrations could inhibit the binding of lzSI-HOPC 8 to E-PnC, and that at 30-to 50-fold higher concentrations, it could also partially inhibit the binding of 12SI-CRP to the sensitized cells. This apparent interaction between CRP and GB4-10 was further explored by direct-binding experiments using a solid-phase assay system. Fig. 4 illustrates a representative binding experiment. Inspection of the curves indicates that in the presence of Ca ++, binding of I~SI-HOPC 8 was observed when as little as 0.8 #g of GB4-10/1 ml were used to coat the microwells. Binding of ~50% of the 125I-HOPC 8 offered required 1.6 #g ofGB4-10/l ml. On the other hand, binding of 125I-CRP was not observed until 6 #g GB4-10/ml were used and 50% binding required 12 #g/ml. In the presence of I mM EDTA, the binding of 125I-CRP to GB4-10 was completely inhibited, whereas the binding of a25I-HOPC 8 was not affected (Fig. 4) . Similar results were obtained with a second independent anti-HOPC 8 MAB, AB1-2. AB1-2 was prepared similarly to GB4-10, but it differs from the latter in fine specificity. Again, binding of 125I-CRP was Ca++-dependent, whereas no Ca ++ requirement was evident for 125I-HOPC 8. Finally, as a control a third unrelated MAB, EB3-7, was used in a similar experiment. EB3-7 has specificity for idiotypic determinants on J558, an al--*3 dextran-binding murine myeloma protein (a,~). Neither 125I-HOPC 8 nor 12~I-CRP bound to microwells coated with ~--30 #g/ml of EB3-7 either in the presence or absence of Ca ++.
Binding of either x25I-CRP or 125I-HOPC 8 to GB4-10 could be inhibited by similar concentrations of KLH-linked phosphocholine (KLH-PC) (Fig. 5) . However, free phosphocholine inhibited only the binding of 125I-CRP, although it failed to inhibit that of lzSI-HOPC 8 at concentrations up to 0.45 raM. Finally, in the presence of Ca ++, the binding of 125I-HOPC 8 to GB4-10 could be inhibited by cold HOPC 8 as well as by a 50-fold higher molar concentration of cold CRP (Fig. 6 ). Substitution of EDTA for Ca ++ abolished the inhibitory ability of CRP without affecting that of HOPC 8. The binding of 12SI-CRP to GB4-I0 could be inhibited by cold CRP but not by HOPC 8 at the highest concentration tested. However, it should be noted that this last experiment was technically difficult because the concentration of GB4-10 used to coat the tubes was ~ 10-fold higher than that used for binding of x25I-HOPC
8.

Discussion
The human acute-phase protein CRP and the murine PCBMP HOPC 8 (a,K) share a common binding specificity for phosphocholine residues of PnC (6, 10) . In addition, CRP and HOPC 8 exhibit similar association constants for the free hapten phosphocholine: 1.6 × 105 M -1 and 2.4 × 105 M -x, respectively (7, 11) . Although no direct comparison has been made, the two proteins should not be expected to have identical fine-binding specificities. Binding of CRP but not of PCBMP to PnC can be inhibited by phosphate monoesters, whereas choline inhibits the binding of PCBMP but not of CRP. A further essential difference between the binding speeificities of the two proteins is the requirement of Ca ++ for CRP. Despite these differences, under the experimental conditions used in this study, the two proteins were found to bind equally well to E-PnC and to require equimolar amounts of phosphocholine for 50% inhibition ( Figs. 1 and 2 ). In addition, cross-inhibition experiments (Fig. 3) indicated that equimolar concentrations of HOPC 8 and CRP were required for 50% inhibition of binding of 125I-HOPC 8 to E-PnC, further emphasizing the similarities between the two proteins in terms of binding specificity and affinity. On the other hand, in the converse experiment, eightfold more HOPC 8 than CRP was required for 50% inhibition of binding of x25I-CRP. This finding could not be readily attributed to differences in affinity or fine specificity of the two proteins. It could be explained though by previous data (32) indicating that CRP may have a secondary binding specificity for N-acetyl-galactosamine residues of PnC.
The overall similarity in binding specificity and affinity between HOPC 8 and CRP raised the possibility of structural similarities in their phosphocholine-binding sites. Such structural homology was previously suggested by Young and Williams (18) who pointed out that certain regions in the primary structure of CRP bear resemblance to Ha and H2 of PCBMP. Monoclonal antibodies with specificity for idiotypic determinants associated with the variable regions of PCBMP should be sensitive probes for such structural homologies because idiotypic determinants are found exclusively on the FV fragment of immunoglobulins (33) and may be associated with antigen-binding sites (34, 35) . In most strains of mice, the anti-phosphocholine response is dominated by a restricted set of antibodies defined by the TEPC 15 idiotype (36), and anti-idiotypic sera to TEPC 15 have been used extensively in genetic and cellular studies of the immune response to phosphocholine. An idiotypic cross-reactivity between a human phosphocholine-binding IgM protein and a murine PCBMP, MOPC 167 has also been reported (37) . Both MAB used in this study were raised against HOPC 8 and recognized an idiotope dependent on H and L chain association for expression. This idiotope was not present in other PCBMP tested, MOPC 167, M511, and W 3207, which have amino acid sequence differences from HOPC 8 in the VH and VL regions and are negative for the TEPC 15 idiotype (9) .
Preliminary experiments indicated that GB4-10 could inhibit the binding of 125I-CRP to E-PnC. However, compared with 125I-HOPC 8, much higher concentrations of GB4-10 were required and only partial inhibition was observed. This finding could perhaps be explained by the previously mentioned secondary-binding specificity of CRP for sugar residues of PnC (32) . It nevertheless raised questions concerning the specificity of the interaction between CRP and GB4-10. The direct-binding experiments (Fig. 4) clearly demonstrated the specificity of the interaction between 125I-CRP and the anti-HOPC 8 MAB. First, no binding of 125I-CRP to EB3-7 an unrelated MAB, was observed. Second, at the highest concentration of GB4-10 used, 66% of the 125I-CRP offered bound to the immobilized MAB. This makes it highly unlikely that contaminants in the CRP preparation, such as anti-phosphocholine antibodies, were responsible for the observed binding. Third, EDTA completely inhibited the binding of ~25I-CRP to either GB4-10 or AB 1-2 without affecting the binding of ~2SI-HOPC 8.
A Ca ++ requirement was observed not only for the binding of 12~I-CRP to GB4-10 and AB 1-2, but also for the inhibition of binding of 12~I-HOPC 8 to GB4-10 by CRP. The Ca ++ dependence of these interactions might be relevant to the role of this anion in the binding of CRP to phosphocholine. CRP has been shown to bind Ca ++ with an association constant of 1.3 × 10 4 M -1 at 25°C and a valence of one to two per subunit (3) . The exact role of Ca ++ in the CRP-phosphocholine interaction is not known, but it has been suggested (3) that it might directly participate in binding the phosphate group. Our present data show that the expression of antigenic determinants of CRP, cross-reacting with idiotypic determinants on HOPC 8, depends on Ca ÷+. Furthermore, these determinants are apparently intimately associated with the phosphocholine-binding site, as indicated by the hapten-inhibition experiments (Fig. 5) . It therefore appears, that Ca ++ acts as an allosteric effector of CRP, essential for the proper conformation of its phosphocholine-binding site. Evidence for Ca++-induced conformational changes of CRP has been previously provided by circular dichroism studies (18) .
The finding that antigenic determinants on CRP, a nonimmunoglobulin molecule, cross-react with idiotypic determinants might be important in understanding the evolutionary origin of antibody-combining sites.
Summary
Binding of human 125I-C-reactive protein (CRP) to sheep erythrocytes sensitized with pneumococcal C polysaccharide (E-PnC) was found to be Ca÷+-dependent and inhibitable by phosphocholine, CRP, and HOPC 8. Binding of 125I-HOPC 8 to EPnC was Ca++-independent but could also be inhibited by phosphocholine, CRP, and HOPC 8. Thus, CRP and HOPC 8, despite a differential Ca ++ requirement, share a common binding specificity for phosphocholine. A monoclonal anti-idiotypic antibody (MAB), GB4-10, prepared in A/J mice immunized with BALB/c HOPC 8 inhibited the binding of both 125I-CRP and 12SI-HOPC 8 to E-PnC. In addition, both proteins bound to GB4-10 immobilized on polysterene tubes. Interestingly, binding of 12~I-CRP to GB4-10 required Ca ++. Similar results were also obtained with another MAB (AB1-2) prepared similarly to GB4-10, whereas neither protein bound to a control MAB (EB3-7) against an al---~3 dextran-binding myeioma protein, J558. Binding of 125I-HOPC 8 to GB4-10 could be inhibited by HOPC 8, keyhole limpet hemocyanin-phosphocholine but not phosphocholine, and in the presence of Ca ++ by CRP. These data indicate that CRP bears antigenic determinants cross-reacting with certain idiotypic determinants on HOPC 8. They also suggest that Ca ++ acts as an allosteric effector, perhaps stabilizing the phosphocholine-binding site of CRP.
